FDA Inspection 1177107 — Cosmax USA, Corporation

Cosmax USA, Corporation — FEI 3002679704

The FDA completed an inspection of Cosmax USA, Corporation on July 22, 2022 in Carteret, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carteret, NJ (United States)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls